Description
A tetracycline antibiotic; has bacteriostatic activity at low concentrations (7.8 μg/ml) and bactericidal activity at high concentrations (15.6 μg/ml) against E. coli; has additive and synergistic effects with penicillin and cephalothin, respectively, in vitro against 34 E. coli and S. aureus strains; active against chloroquine-susceptible and -resistant P. falciparum strains (IC50s = 45-208 μM); reduces Aβ40 fibrilization (IC50 = 59 μM in an immune assay); completely inhibits Aβ40-induced cellular toxicity at a concentration of 20 μM
Formal name: 4-(dimethylamino)-1,4S,4aS,5,5aS,6S,11,12aS-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-N-(1-pyrrolidinylmethyl)-2-naphthacenecarboxamide
Synonyms: Pyrrolidinylmethyltetracycline|SQ 15,659
Molecular weight: 527.6
CAS: 751-97-3
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Antibiotics|Tetracyclines||Product Type|Biochemicals|Antiparasitics|Antiprotozoals||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Bacterial Diseases||Research Area|Infectious Disease|Parasitic Diseases|Malaria||Research Area|Neuroscience|Neurodegenerative Disorders|Alzheimer’s Disease